News PEAR raises $50m to develop digital therapeutics business PEAR Therapeutics has raised $50m in a new financing round to fund development of its prescription digital therapeutics business.
News ePatientFinder to grow clinical trial matching platform afte... $8.2 million in funding will be used to expand the company's next stage of growth.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.